Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

STENOCARE CEO looks ahead after the first year as a listed company

CEO of STENOCARE A/S (“STENOCARE”), Thomas Schnegelsberg, reflects on the first 12 months as a public company and looks ahead to what he calls STENOCARE 2.0 and beyond:THE FIRST 12 MONTHS – ALL TARGETS MET It was a proud moment when we could ring the bell and start trading on the 26th of October 2018 as the first ever IPO of a licensed provider of medical cannabis in Europe. Looking back, I am pleased to say that since then we have met or exceeded our short-term objectives. First mover: We were the first company to secure all required licenses for cultivating and import of medical

Tecnotree Board of Directors approves the Long Term Incentive (LTI) plan for 2019-2022 and the issuance of shares to Tecnotree; Board of Directors resolves upon a directed share issue to CEO

Tecnotree announced today that its Board of Directors has approved the company's employee incentive program for 2019-2022 (the "LTI Plan") designed to align the participants' focus with Tecnotree’s growth strategy and long-term success. The LTI Plan includes the following instrument: · Restricted Share Units (RSUs) giving a contractual right to receive shares over the next 3 year period as per an equated semi-annual vesting schedule. LTI Plan Objective Having shown recovery from a difficult period where bonus pay-outs and salary increments were suspended for the key employees and

Management change at Catena

Catena appoints Sofie Bennsten as Deputy CEO and CFO. Sofie will succeed the current Deputy CEO and CFO, Peter Andersson, who has expressed his desire to reduce his current involvement following many successful years in this position. Peter will continue to be involved in Catena in a new role as Head of Treasury. In connection with this change, Jörgen Eriksson, Regional Manager Malmö, will be appointed Deputy CEO of the company. All of these management changes will be implemented at the end of April 2020.31 October 2019, 8:45 a.m. CET Sofie Bennsten has most recently been employed in the

Year-end report 2018-09-01 - 2019-08-31

Nextcell Pharma AB ("NXTCL") today announces the year-end report for the 2018/2019 fiscal year (2018-08-31 2019-08-31)Twelve months (2018-09-01 until 2019-08-31) · Operating income amounted to SEK 1 964 132 (655 413). · Operating result amounted to SEK -21 450 784 (-14 032 294).                · Earnings per share* amounted to SEK -1.36 (-0.61). · Cash and bank amounted to SEK 20 128 185 (3 115 876). · Solidity** amounted to 85.9 (59.2) %. Fourth quarter (2019-06-01 until 2019-08-31) · Operating income amounted to SEK 551 708 (127 868). · Operating result

Invitation to presentation in conjunction with Net Gaming's third quarter of 2019

On Thursday 14 November at 08:30 a.m. CET Net Gaming's interim report for the third quarter of 2019 will be published. At 10:00 a.m. the same day a presentation of Net Gaming's interim report for the third quarter of 2019, will be presented.CEO Marcus Teilman and CFO Gustav Vadenbring will present the results, followed by a Q&A session. The presentation will be held in English and will be webcasted live through netgaming.se or via https://tv.streamfabriken.com/net-gaming-europe-q3-2019 The join the conference via phone, please dial-in using any of the numbers below: From Sweden:

Announcement of change in number of shares and votes in Tethys Oil

In October 2019, the number of shares and votes in Tethys Oil AB (publ) has changed due to exercise of warrants under the long-term incentive program approved by the annual general meeting on 18 May 2016. The number of shares and votes in Tethys Oil has in October 2019 increased by 398,650 shares and votes.As at 31 October 2019, the total number of shares and votes in the company amounted to 36,294,960. For further information, please contactMagnus Nordin, Managing Director, phone +46 8 505 947 00 This information is information that Tethys Oil AB (publ) is obliged to make public

Unique screening on ice in Kungsträdgården

Stockholm Internatinonal Film Festival is arranging a Winter Cinema at an ice screen in Kungsträdgården, during the weekend November 9-10. The actress Rosanna Arquette opens the Winter Cinema, November 9th at 4:00 pm, as the sun sets over Stockholm. The event is free with the purpose of screening quality cinema to the wider audience. The ice is harvested from Torneälven in Jukkasjärvi and weighs 6 tons. Picture of the ice screen 2009. – Ten years ago, we created an unforgettable moment for the Stockholmers when Susan Sarandon visited the festival and opened the world’s first

Invitation – Third quarter results presentation 2019

Invitation, Hillerstorp 31st of October 2019, 08:30 CET Troax Group´s report for the third quarter 2019 will be published at 12:30 CET, November 7.Thomas Widstrand, President and CEO, will present the financial results on a conference call the same day at 16:00 CET. The conference will be held in English. The report and a presentation will be available on https://old.troax.com/en/investors/financial-reports In order to participate in the conference call, please use the dial-in details below. Callers are encouraged to dial in 5-10 minutes in advance as a short registration with the

Hunter Group ASA - Successful delivery and successful completion of sale of H.No. 5457

Oslo, 31 October 2019 With reference to the press release dated June 17th 2019, Hunter Tankers AS, a wholly owned subsidiary of Hunter Group ASA, is pleased to announce that it, today at 0730hrs CET, took delivery of its third vessel, H.No. 5457, and subsequently delivered her to her new owner in accordance with the Memorandum of Agreement.  All funds have been transferred and the transaction is complete. For further information, please contact: Erik Frydendal, CEO +47 957 72 947, ef@huntergroup.no Lars Brynildsrud, CFO +47 932 60 882, lb@huntergroup.no

Veidekke ASA: To build new stage at Vollebekk

OBOS Nye Hjem has awarded Veidekke the contract to build the Bien housing cooperative, which is the fourth building stage with 116 apartments and parking facilities at Vollebekk in eastern Oslo. This is a design and build construction contract valued at NOK 222 million, excluding VAT.This stage comprises a three- and four-part structure from four to six storeys above ground, and garage, bicycle parking, storage rooms and technical rooms below ground. The 116 one, two and three bedroom apartments vary in size from 43 to 97 square metres. There will be several communal roof terraces with

DOF Subsea contract for Hywind Tampen is a strategic breakthrough

DOF Subsea signs today a contract with Kværner to collaborate and deliver Marine Operations for Equinor`s Hywind Tampen Project. The contract shall be executed in a 50/50 partnership (joint venture) with Kværner. “Hywind Tampen will be the world’s largest floating offshore wind farm and is vital for industrialising solutions and reducing costs for future offshore wind power projects. The deep-water floating renewables market is on the verge of commercialization, and therefore this contract has strategic importance to DOF Subsea” says Mons Aase, CEO in DOF Subsea. The Hywind Tampen

CapMan Infra and Telia Company to accelerate roll-out of fibre networks in Finland

CapMan Infra press release31 October 2019 at 09.00 a.m. EET CapMan Infra and Telia Company to accelerate roll-out of fibre networks in Finland CapMan Infra has agreed on a majority investment in a joint venture to be established with Telia Company to invest into and deploy fibre-to-the-home (FTTH) infrastructure in Finland. The joint venture will acquire Telia Finland’s existing Avoin Kuitu fibre assets and will be one of the largest FTTH network owners and operators in Finland. One of the key goals in the Finnish Government Programme 2019 is promoting the construction of more

Q3 Report 2019 – invitation to conference call and audiocast

On Thursday November 14, at 04.00 p.m. CET IRRAS will host a conference call and an online presentation of its Q3 2019 interim report (which will have been published earlier on the 14[th] at 08.00 a.m. CET). The presentation will be held in English. The dial-in numbers for the conference call are: Sweden: +46 8 50 55 83 54 Rest of the world: +44 33 33 00 92 74 The presentation will be webcast and can be accessed from the following web address: https://financialhearings.com/event/11742 Speakers: President CEO Kleanthis G. Xanthopoulos, Ph.D., CCO Will Martin and CFO Sabina

New number of shares in Handelsbanken

Due to an exchange of convertible notes in Svenska Handelsbanken AB, the number of Class A shares has increased by 3 315 419 shares and the number of votes has increased by 3 315 419.Following the increase, the total number of shares in Handelsbanken is 1 977 246 946 of which 1 941 995 617 are Class A shares and 35 251 329 are Class B shares.The total number of votes in Handelsbanken is 1 945 520 749,9. The share capital amounts to SEK 3 064 732 766,30 after the increase.    For further information, please contact:Lars Höglund, Head of Investor Relations: +46 8–701 51 70,+46 70–

Invitation to a press conference: Kamux Corporation’s Interim Report for January—September 2019

Kamux Corporation    Investor News    31 October, 2019 at 9:00 Invitation to a press conference: Kamux Corporation’s Interim Report for January—September 2019 Kamux Corporation will publish its Interim Report for January—September 2019 on Friday, 8 November 2019 at about 9:00 a.m. Kamux will hold an Interim Report press conference for media and analysts on 8 November, 2019 at hotel GLO Kluuvi, Video Wall meeting room, address Kluuvikatu 4, Helsinki, at 11:00 (Finnish time) in Finnish and then in English at around 11:30. You can follow the press conference webcasted live through

Terveystalo Group Interim Report 1 January – 30 September 2019

Strong organic growth improved underlying profitabilityTerveystalo Plc Interim Report 31 October 2019 at 9:00 a.m. EET This release is a summary of Terveystalo's Half-Year Report for 1 January – 30 September 2019. The full release is available as an attachment to this stock exchange release and is available on our website at https://www.terveystalo.com/en/investors/Financial-information/ . July–September 2019 in brief · Revenue increased by 46.0 percent year-on-year to EUR 234.0 million (160.3)   · Adjusted1) earnings before interest, taxes and amortization (EBITA) before IFRS

SaltX Technology Holding AB (publ) Interim report 3, 2019

Interim report quarter 3, 2019Financial eventsQuarter 3*-Net sales totaled MSEK 0.2 (1.5)-Operating profit/loss (EBIT) amounted to MSEK -7.0* (-11.6)-Cash flow from operating activities amounted to MSEK -12.4 (-6.4)-Earnings per share before and after dilution were SEK -0.10 (-0.23) Period January — September-Net sales totaled to MSEK -0.7 (4.8)-Operating profit/loss (EBIT) amounted to MSEK -72,9 (-41.3) -Cash flow from operating activities amounted to MSEK -48.7 (-35.6)-Earnings per share before and after dilution were SEK -1.06 (-0.73) Significant events Third

Proact to embed technical resources to support and bolster IT services at NHS Blood and Transplant

Leading independent data centre and cloud services provider Proact is set to help improve NHS Blood and Transplant’s technical and IT delivery capabilities by providing augmented resources on a call-off basis. The public body will introduce skills from Proact into its IT function covering networking, security, public cloud and more.NHS Blood and Transplant provides blood, diagnostic and therapeutic services to every NHS Trust in England, and organ donation and transplantation services across the UK. To support these potentially lifesaving services, the IT function is focusing on modernising

Hansa Biopharma Interim Report January–September 2019

Positive results from a pooled analysis in highly sensitized patientsHighlights for the third quarter 2019 - Positive results from a pooled analysis of Phase 2 trials with imlifidase for desensitization in highly sensitized kidney transplant patients were presented for the first time at the European Society of Organ Transplantation’s (ESOT) Congress on September 17. Imlifidase enabled kidney transplantation in 46 sensitized patients. The data presented was fully in line with previously reported data on transplantation of highly sensitized patients with imlifidase. - Hansa Biopharma

Wulff Group Plc’s Interim Report for January 1 – September 30, 2019

INTERIM REPORT    OCTOBER 31, 2019 AT 9.00 A.M. Relative profitability increased, net sales decreased This is a summary of Wulff Group Plc’s interim report for January-September 2019. Wulff Group’s interim report as a whole is attached as a PDF file to this stock exchange release and it is also available on the company’s website www.wulff-group.com. 1.7. – 30.9.2019 BRIEFLY ·  Net sales totalled EUR 12.0 million (13.0), decreased by 7.8% ·  EBITDA was EUR 0.4 million (0.4), 3.6% of net sales (2.8) and comparable EBITDA was EUR 0.6 million (0.4), 4.6% of net sales (2.8) ·

Telia Company and CapMan Infra to jointly increase fiber penetration in Finland

Telia Company will accelerate the roll-out of open fiber in Finland. The continued effort to create best network experience across platforms will be performed in co-operation with Capman Infra, the infrastructure investments arm of Nordic private asset management firm CapMan.The fiber roll-out targets households (single dwelling units, SDUs) across Finland. According to the agreement with CapMan Infra, Telia Company will hold a 40 percent stake in a new company which will take over Telia Finland’s existing SDU fiber roll-out business ‘Avoin Kuitu’, which currently has roughly 20,000 homes

INTERIM REPORT, January-September 2019

Still benefitting from strong demand Third quarter of 2019 · Consolidated net sales increased by 16 percent to SEK 901 m (778), of which organic growth amounted to 10 percent. Acquisitions contributed by 4 percent and currency by 2 percent · Net sales in Products & Solutions amounted to SEK 671 m (575) and Installation Services toSEK 262 m (235) · EBITDA increased by 35 percent to SEK 137 m (102), whereof SEK 13 m refers to effects from IFRS 16 · Operating profit (EBIT) increased by 27 percent to SEK 109 m (86), whereof SEK 1 m refers to effects from IFRS 16 · ROCE on

Sobi publishes report for third quarter 2019

Swedish Orphan Biovitrum AB (publ)  (Sobi™) today announces its results for the third quarter 2019. Revenue growth in the quarter was 27 per cent with revenue of SEK 2,930 M (2,315). EBITA was SEK 1,099 M, resulting in an EBITA margin of 38 per cent. Highlights (July – September) · Total revenue of SEK 2,930 M (2,315), 27 per cent revenue growth in the quarter compared with Q3 2018 (22 per cent at constant exchange rates (CER)) · EBITA(1)  was SEK 1,099 M (933), an increase of 18 per cent · Earnings per share (EPS) of SEK 1.84 (2.31) · Net debt(1) of

Outokumpu third quarter interim statement – Challenging quarter due to a weak market and a sharp increase in the price of nickel, Group adjusted EBITDA at EUR 45 million

Interim statementOctober 31, 2019 at 9.00 am EET Outokumpu third quarter interim statement – Challenging quarter due to a weak market and a sharp increase in the price of nickel, Group adjusted EBITDA at EUR 45 million Highlights in Q3 2019 · Stainless steel deliveries were 533,000 tonnes (582,000 tonnes)1. · Adjusted EBITDA was EUR 45 million (EUR 128 million). · EBITDA was EUR 45 million (EUR 128 million). · Operating cash flow was EUR 12 million (EUR 61 million). · Net debt was EUR 1,336 million (June 30, 2019: EUR 1,307 million). · Gearing was 51.4% (June 30,

There are no items matching the current filter
There are no more items matching the current filter
Back to top